Tamtam Try Tamtam free
CVS Health logo

CVS Health account plan

Comprehensive community health support

At a glance

CVS Health is a U.S. health solutions company: Aetna insurance, the CVS Caremark PBM, about 9,000 pharmacies and 1,000+ clinics; $402.1 billion 2025 revenue.

CVS Health is a U.S. health solutions company that combines a health insurer (Aetna, serving an estimated more than 37 million people), a pharmacy benefits manager (CVS Caremark, approximately 87 million plan members), approximately 9,000 retail locations and more than 1,000 walk-in and primary care clinics. Its customers are consumers, employers, health plans and government programs; the U.S. federal government is a major customer, with Health Care Benefits revenues from it at approximately 20% of consolidated total revenues in 2025. In fiscal 2025 total revenues were $402.1 billion (+7.8%), adjusted operating income $14.4 billion and net income attributable to CVS Health $1.8 billion, after a $5.7 billion goodwill impairment on Health Care Delivery. It employs over 300,000 colleagues, primarily in the U.S., and is headquartered in Woonsocket, Rhode Island. The company does not plan to expand internationally.

Business units

Strategic priorities

Aetna margin recovery
After adding $2.5 billion of operating income in 2025, Aetna targeted adjusted operating income of $3.6-$3.9 billion for 2026 with a medical benefit ratio of 90.5% +/- 50 bps, helped by the exit from the individual exchange business.
Mid-teens earnings growth through 2028
At the December 2025 Investor Day management set a mid-teens adjusted EPS CAGR through 2028, with growth from every business and not counting buybacks or the upside from the new open engagement platform.
Technology-powered consumer engagement
CVS made a $20 billion commitment to technology over 10 years, is building an integrated CVS Health app across Aetna, Caremark, CVS Pharmacy and MinuteClinic, and plans an open engagement platform that other PBMs, payers and providers could plug into.
Partner of choice for providers
One of the four strategic pillars is to be the partner of choice for providers by addressing prior authorization, administrative complexity and interoperability; Caremark reports 90% of prior authorizations approved within 24 hours.
Lowest net cost and specialty leadership at Caremark
Caremark prioritises lowest net cost, transparency and specialty, with TrueCost net-cost drug-level pricing covering more than 12,000 drugs and biosimilars seen growing from approximately a $10 billion market to more than $100 billion by decade end.
Margin over growth in care delivery and retail
Oak Street Health has shifted from clinic growth to margin improvement, targeting mid to high single-digit margins long term, while CVS Pharmacy now aims for at least flat earnings each year and is moving almost 500 of 900 MinuteClinics to primary care capacity.

Latest results

In Q2 2026 (three months to June 30, 2026) total revenues rose 7.3% to $106.1 billion, with growth in all operating segments, and adjusted operating income rose 35.4% to $5.2 billion. GAAP diluted EPS was $2.31 (Q2 2025: $0.80) and adjusted EPS $2.58 ($1.81), mainly from Aetna, whose adjusted operating income rose 85.5% to $2.4 billion as the medical benefit ratio improved to 87.4% from 89.9%. Health Services revenue grew 11.5% to $51.8 billion and Pharmacy & Consumer Wellness adjusted operating income rose 10.2%, with prescriptions filled +4.3%. Full-year 2026 guidance was raised to total revenues of at least $414.0 billion, adjusted EPS of $7.90-$8.10 (from $7.30-$7.50) and cash flow from operations of at least $11.5 billion, while management keeps "a cautious view" given elevated cost trends and possible macro headwinds.

Investments and deals

Technology and digital capex
Gross capital expenditures were approximately $2.8 billion in 2025, 77% of it for technology, digital and other strategic initiatives; capex is planned at around $3 billion a year, within a $20 billion technology commitment over 10 years.
Rite Aid assets and prescription files
CVS acquired Rite Aid prescription files and Rite Aid stores in Idaho, Oregon and Washington ($465 million total consideration), completed in Q3 2025; management cites 63 Pacific Northwest stores and over 600 file buys.
Agentic AI in operations
Agentic AI is being deployed in Aetna and CVS Caremark call centers, and the second-generation Aetna Claims Assist Manager cuts processing time by over 20% for complex claims needing manual review.
Portfolio exits and store footprint
In 2025 CVS sold its MSSP business, wound down ACO REACH, deconsolidated Omnicare after its Chapter 11 filing, exited the individual exchanges, and closed 243 stores while opening or acquiring 87.
Deleveraging
No share repurchases in 2025 or 2026 while the company deleverages to a mid-BBB rating; $4.0 billion of senior notes were issued in August 2025 and the quarterly dividend of $0.665 is expected to be maintained through 2026.

Challenges and risks

Elevated medical utilization
Utilization is expected to stay elevated in 2026 and could pressure Aetna and the care delivery assets; value-based care is described as being in "a trough period".
PBM regulation and pricing pressure
Comprehensive PBM legislation is proposed or enacted in a majority of states and federally, with more rebates passed to clients, limits on spread pricing and a risk of laws barring PBM-affiliated pharmacies.
Government funding and rates
CVS depends on Medicare and Medicaid funding, rates, risk adjustment and star ratings; CMS proposed a 0.09% average 2027 Medicare Advantage rate increase, and the CEO names government's role as his biggest challenge.
Care delivery write-downs
A $5.7 billion goodwill impairment hit Oak Street Health and Signify Health in 2025; $4.2 billion of goodwill remains and further impairment is "reasonably possible".
Litigation and credit outlook
About $1.2 billion of legacy litigation charges and a $320 million opioid charge were taken in 2025, and debt ratings carry a negative outlook at Fitch and S&P.

What leadership says

“We righted the ship, charted a new path forward, and now entering parts of the market that either others can't and/or simply are not equipped to be able to compete.”

David Joyner, Chairman and CEO · CVS Health 2025 Investor Day, December 9, 2025

“technology will become the enabler for our growth.”

David Joyner, Chairman and CEO · CVS Health 2025 Investor Day, December 9, 2025

“As our businesses work together to deliver a technology-powered care engagement experience, we continue to deliver strong performance.”

David Joyner, Chairman and CEO · Q2 2026 earnings release, August 5, 2026

“We have 500 million phone calls a year into the pharmacy”

David Joyner, Chairman and CEO · Conversation with David M. Rubenstein, The Economic Club of Washington, D.C., July 9, 2026

Where a supplier can help

Call deflection and conversational AI
Tied to the technology-powered consumer engagement priority and the agentic AI investment: with 500 million pharmacy calls a year, suppliers of conversational AI, self-service and prescription status tooling can help take calls out of the system.
Provider friction and prior authorization
Tied to the partner-of-choice priority: vendors in prior authorization automation, interoperability and claims processing can support CVS's push to cut administrative complexity for providers.
Care delivery cost efficiency
Tied to the care delivery margin priority and the goodwill impairment challenge: Oak Street's shift to margin improvement favours suppliers that lower clinic operating costs or improve risk-adjustment accuracy.
Medical cost management for Aetna
Tied to the Aetna margin recovery priority and the elevated utilization challenge: analytics, trend forecasting and care navigation offerings that help hold the medical benefit ratio are directly relevant.
Regulatory and compliance support
Tied to the PBM regulation and litigation challenges: compliance, transparency reporting and pricing-model tooling can help Caremark operate under state and federal PBM rules.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like CVS Health?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about CVS Health

What does CVS Health do?

CVS Health is a U.S. health solutions company that runs Aetna health insurance, the CVS Caremark pharmacy benefits manager, about 9,000 CVS Pharmacy retail locations and more than 1,000 walk-in and primary care clinics, including MinuteClinic and Oak Street Health.

What is CVS Health's revenue?

Total revenues were $402.1 billion in fiscal 2025 (+7.8%). In Q2 2026 revenues were $106.1 billion, and the company guides to at least $414.0 billion for full-year 2026.

How many employees does CVS Health have?

CVS Health employed over 300,000 colleagues at the end of 2025, approximately 73% full-time, primarily in the U.S.

Who leads CVS Health?

David Joyner has been President and CEO since October 2024 and Chair since January 2026. Brian Newman is CFO and Steven Nelson is President of Aetna.

What is CVS Health's strategy?

The ambition is to be "America's most trusted healthcare company", built on four pillars: best-in-class execution, transforming consumer experiences, being the partner of choice for providers, and enterprise capabilities connected by technology. The financial target is a mid-teens adjusted EPS CAGR through 2028.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)